[Cannabinoids in patients with autism spectrum disorders]
Virgilio S, Alcaraz A, Pichon-Riviere A, Augustovski F, García Martí S, Bardach A, Ciapponi A
Record ID 32017000288
Spanish
Authors' recommendations:
No available scientific evidence which would allow determining the effectiveness of cannabinoids use for the treatment of patients with autism spectrum disorders was found. The clinical practice guidelines consulted do not mention the use of this technology in autism spectrum disorders and no coverage policies considering its use were found.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Analgesics
- Autism Spectrum Disorder
- Autistic Disorder
- Cannabinoids
- Humans
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.